Anti‐tumorigenic effects of naive and TLR4‐primed adipose‐derived mesenchymal stem cells on pancreatic ductal adenocarcinoma cells
Background One of the main reasons for the unsuccessful treatment of pancreatic cancer is the intense desmoplastic pancreatic microenvironment. In the literature, the effects of mesenchymal stem cells (MSCs) and their inflammatory phenotypes on cancer cells have been a subject of controversy. Theref...
Saved in:
Published in | Cancer medicine (Malden, MA) Vol. 13; no. 2; pp. e6964 - n/a |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
John Wiley & Sons, Inc
01.01.2024
John Wiley and Sons Inc |
Subjects | |
Online Access | Get full text |
ISSN | 2045-7634 2045-7634 |
DOI | 10.1002/cam4.6964 |
Cover
Loading…
Abstract | Background
One of the main reasons for the unsuccessful treatment of pancreatic cancer is the intense desmoplastic pancreatic microenvironment. In the literature, the effects of mesenchymal stem cells (MSCs) and their inflammatory phenotypes on cancer cells have been a subject of controversy. Therefore, it is crucial to elucidate the underlying mechanisms of this interaction, especially in the context of pancreatic cancer. We aimed to investigate the effects of naive, TLR4‐activated, and TLR4‐inhibited phenotypes of adipose‐derived MSCs (ADMSC) on pancreatic ductal cell line (Panc‐1).
Methods and Materials
Adipose‐derived MSCs were induced into a proinflammatory phenotype using a 0.5 μg/mL dose of TLR4 agonist, while an anti‐inflammatory phenotype was generated in ADMSCs using a 25 μg/mL dose of TLR4 antagonist. We observed that the proliferation of Panc‐1 cells was inhibited when naive ADMSCs:Panc‐1(10:1) and proinflammatory ADMSCs:Panc‐1(10:1) were directly cocultured.
Results
In indirect coculture, both naive and proinflammatory ADMSCs exhibited a significant 10‐fold increase in their inhibitory effect on the proliferation and colony forming capacity of Panc‐1 cells, with the added benefit of inducing apoptosis. In our study, both naive and proinflammatory ADMSCs were found to regulate the expression of genes associated with metastasis (MMP2, KDR, MMP9, TIMP1, IGF2R, and COL1A1) and EMT (CDH1, VIM, ZEB1, and CLDN1) in Panc‐1 cells. Remarkably, both naive and proinflammatory ADMSCs demonstrated antitumor effects on Panc‐1 cells. However, it was observed that anti‐inflammatory ADMSCs showed tumor‐promoting effects instead. Furthermore, we observed a reciprocal influence between ADMSCs and Panc‐1 cells on each other's proinflammatory cytokine expressions, suggesting a dynamic interplay within the tumor microenvironment.
Conclusions
These findings underscore the significance of both the naive state and different inflammatory phenotypes of MSCs in the microenvironment and represent a pivotal step toward the development of novel therapeutic approaches for pancreatic cancer. Understanding the intricate interactions between MSCs and cancer cells may open new avenues for targeted interventions in cancer therapy.
In our study, we showed that the tumorigenic effects of ADMSCs on Panc‐1 cells were altered when stimulated via TLR4 signaling, but this effect was altered when naive ADMSCs and ADMSCs with pro‐inflammatory character stimulated by TLR4 agonist exerted anticarcinogenic effects on Panc‐1 cells. Anti‐inflammatory ADMSCs, on the other hand, showed tumor‐promoting effects. Understanding the role of MSCs in the tumor microenvironment will be a guiding factor for the development of microenvironment‐targeted therapeutic approaches in the future. |
---|---|
AbstractList | One of the main reasons for the unsuccessful treatment of pancreatic cancer is the intense desmoplastic pancreatic microenvironment. In the literature, the effects of mesenchymal stem cells (MSCs) and their inflammatory phenotypes on cancer cells have been a subject of controversy. Therefore, it is crucial to elucidate the underlying mechanisms of this interaction, especially in the context of pancreatic cancer. We aimed to investigate the effects of naive, TLR4-activated, and TLR4-inhibited phenotypes of adipose-derived MSCs (ADMSC) on pancreatic ductal cell line (Panc-1).BACKGROUNDOne of the main reasons for the unsuccessful treatment of pancreatic cancer is the intense desmoplastic pancreatic microenvironment. In the literature, the effects of mesenchymal stem cells (MSCs) and their inflammatory phenotypes on cancer cells have been a subject of controversy. Therefore, it is crucial to elucidate the underlying mechanisms of this interaction, especially in the context of pancreatic cancer. We aimed to investigate the effects of naive, TLR4-activated, and TLR4-inhibited phenotypes of adipose-derived MSCs (ADMSC) on pancreatic ductal cell line (Panc-1).Adipose-derived MSCs were induced into a proinflammatory phenotype using a 0.5 μg/mL dose of TLR4 agonist, while an anti-inflammatory phenotype was generated in ADMSCs using a 25 μg/mL dose of TLR4 antagonist. We observed that the proliferation of Panc-1 cells was inhibited when naive ADMSCs:Panc-1(10:1) and proinflammatory ADMSCs:Panc-1(10:1) were directly cocultured.METHODS AND MATERIALSAdipose-derived MSCs were induced into a proinflammatory phenotype using a 0.5 μg/mL dose of TLR4 agonist, while an anti-inflammatory phenotype was generated in ADMSCs using a 25 μg/mL dose of TLR4 antagonist. We observed that the proliferation of Panc-1 cells was inhibited when naive ADMSCs:Panc-1(10:1) and proinflammatory ADMSCs:Panc-1(10:1) were directly cocultured.In indirect coculture, both naive and proinflammatory ADMSCs exhibited a significant 10-fold increase in their inhibitory effect on the proliferation and colony forming capacity of Panc-1 cells, with the added benefit of inducing apoptosis. In our study, both naive and proinflammatory ADMSCs were found to regulate the expression of genes associated with metastasis (MMP2, KDR, MMP9, TIMP1, IGF2R, and COL1A1) and EMT (CDH1, VIM, ZEB1, and CLDN1) in Panc-1 cells. Remarkably, both naive and proinflammatory ADMSCs demonstrated antitumor effects on Panc-1 cells. However, it was observed that anti-inflammatory ADMSCs showed tumor-promoting effects instead. Furthermore, we observed a reciprocal influence between ADMSCs and Panc-1 cells on each other's proinflammatory cytokine expressions, suggesting a dynamic interplay within the tumor microenvironment.RESULTSIn indirect coculture, both naive and proinflammatory ADMSCs exhibited a significant 10-fold increase in their inhibitory effect on the proliferation and colony forming capacity of Panc-1 cells, with the added benefit of inducing apoptosis. In our study, both naive and proinflammatory ADMSCs were found to regulate the expression of genes associated with metastasis (MMP2, KDR, MMP9, TIMP1, IGF2R, and COL1A1) and EMT (CDH1, VIM, ZEB1, and CLDN1) in Panc-1 cells. Remarkably, both naive and proinflammatory ADMSCs demonstrated antitumor effects on Panc-1 cells. However, it was observed that anti-inflammatory ADMSCs showed tumor-promoting effects instead. Furthermore, we observed a reciprocal influence between ADMSCs and Panc-1 cells on each other's proinflammatory cytokine expressions, suggesting a dynamic interplay within the tumor microenvironment.These findings underscore the significance of both the naive state and different inflammatory phenotypes of MSCs in the microenvironment and represent a pivotal step toward the development of novel therapeutic approaches for pancreatic cancer. Understanding the intricate interactions between MSCs and cancer cells may open new avenues for targeted interventions in cancer therapy.CONCLUSIONSThese findings underscore the significance of both the naive state and different inflammatory phenotypes of MSCs in the microenvironment and represent a pivotal step toward the development of novel therapeutic approaches for pancreatic cancer. Understanding the intricate interactions between MSCs and cancer cells may open new avenues for targeted interventions in cancer therapy. Background One of the main reasons for the unsuccessful treatment of pancreatic cancer is the intense desmoplastic pancreatic microenvironment. In the literature, the effects of mesenchymal stem cells (MSCs) and their inflammatory phenotypes on cancer cells have been a subject of controversy. Therefore, it is crucial to elucidate the underlying mechanisms of this interaction, especially in the context of pancreatic cancer. We aimed to investigate the effects of naive, TLR4‐activated, and TLR4‐inhibited phenotypes of adipose‐derived MSCs (ADMSC) on pancreatic ductal cell line (Panc‐1). Methods and Materials Adipose‐derived MSCs were induced into a proinflammatory phenotype using a 0.5 μg/mL dose of TLR4 agonist, while an anti‐inflammatory phenotype was generated in ADMSCs using a 25 μg/mL dose of TLR4 antagonist. We observed that the proliferation of Panc‐1 cells was inhibited when naive ADMSCs:Panc‐1(10:1) and proinflammatory ADMSCs:Panc‐1(10:1) were directly cocultured. Results In indirect coculture, both naive and proinflammatory ADMSCs exhibited a significant 10‐fold increase in their inhibitory effect on the proliferation and colony forming capacity of Panc‐1 cells, with the added benefit of inducing apoptosis. In our study, both naive and proinflammatory ADMSCs were found to regulate the expression of genes associated with metastasis (MMP2, KDR, MMP9, TIMP1, IGF2R, and COL1A1) and EMT (CDH1, VIM, ZEB1, and CLDN1) in Panc‐1 cells. Remarkably, both naive and proinflammatory ADMSCs demonstrated antitumor effects on Panc‐1 cells. However, it was observed that anti‐inflammatory ADMSCs showed tumor‐promoting effects instead. Furthermore, we observed a reciprocal influence between ADMSCs and Panc‐1 cells on each other's proinflammatory cytokine expressions, suggesting a dynamic interplay within the tumor microenvironment. Conclusions These findings underscore the significance of both the naive state and different inflammatory phenotypes of MSCs in the microenvironment and represent a pivotal step toward the development of novel therapeutic approaches for pancreatic cancer. Understanding the intricate interactions between MSCs and cancer cells may open new avenues for targeted interventions in cancer therapy. In our study, we showed that the tumorigenic effects of ADMSCs on Panc‐1 cells were altered when stimulated via TLR4 signaling, but this effect was altered when naive ADMSCs and ADMSCs with pro‐inflammatory character stimulated by TLR4 agonist exerted anticarcinogenic effects on Panc‐1 cells. Anti‐inflammatory ADMSCs, on the other hand, showed tumor‐promoting effects. Understanding the role of MSCs in the tumor microenvironment will be a guiding factor for the development of microenvironment‐targeted therapeutic approaches in the future. BackgroundOne of the main reasons for the unsuccessful treatment of pancreatic cancer is the intense desmoplastic pancreatic microenvironment. In the literature, the effects of mesenchymal stem cells (MSCs) and their inflammatory phenotypes on cancer cells have been a subject of controversy. Therefore, it is crucial to elucidate the underlying mechanisms of this interaction, especially in the context of pancreatic cancer. We aimed to investigate the effects of naive, TLR4-activated, and TLR4-inhibited phenotypes of adipose-derived MSCs (ADMSC) on pancreatic ductal cell line (Panc-1).Methods and MaterialsAdipose-derived MSCs were induced into a proinflammatory phenotype using a 0.5 μg/mL dose of TLR4 agonist, while an anti-inflammatory phenotype was generated in ADMSCs using a 25 μg/mL dose of TLR4 antagonist. We observed that the proliferation of Panc-1 cells was inhibited when naive ADMSCs:Panc-1(10:1) and proinflammatory ADMSCs:Panc-1(10:1) were directly cocultured.ResultsIn indirect coculture, both naive and proinflammatory ADMSCs exhibited a significant 10-fold increase in their inhibitory effect on the proliferation and colony forming capacity of Panc-1 cells, with the added benefit of inducing apoptosis. In our study, both naive and proinflammatory ADMSCs were found to regulate the expression of genes associated with metastasis (MMP2, KDR, MMP9, TIMP1, IGF2R, and COL1A1) and EMT (CDH1, VIM, ZEB1, and CLDN1) in Panc-1 cells. Remarkably, both naive and proinflammatory ADMSCs demonstrated antitumor effects on Panc-1 cells. However, it was observed that anti-inflammatory ADMSCs showed tumor-promoting effects instead. Furthermore, we observed a reciprocal influence between ADMSCs and Panc-1 cells on each other's proinflammatory cytokine expressions, suggesting a dynamic interplay within the tumor microenvironment.ConclusionsThese findings underscore the significance of both the naive state and different inflammatory phenotypes of MSCs in the microenvironment and represent a pivotal step toward the development of novel therapeutic approaches for pancreatic cancer. Understanding the intricate interactions between MSCs and cancer cells may open new avenues for targeted interventions in cancer therapy. One of the main reasons for the unsuccessful treatment of pancreatic cancer is the intense desmoplastic pancreatic microenvironment. In the literature, the effects of mesenchymal stem cells (MSCs) and their inflammatory phenotypes on cancer cells have been a subject of controversy. Therefore, it is crucial to elucidate the underlying mechanisms of this interaction, especially in the context of pancreatic cancer. We aimed to investigate the effects of naive, TLR4-activated, and TLR4-inhibited phenotypes of adipose-derived MSCs (ADMSC) on pancreatic ductal cell line (Panc-1). Adipose-derived MSCs were induced into a proinflammatory phenotype using a 0.5 μg/mL dose of TLR4 agonist, while an anti-inflammatory phenotype was generated in ADMSCs using a 25 μg/mL dose of TLR4 antagonist. We observed that the proliferation of Panc-1 cells was inhibited when naive ADMSCs:Panc-1(10:1) and proinflammatory ADMSCs:Panc-1(10:1) were directly cocultured. In indirect coculture, both naive and proinflammatory ADMSCs exhibited a significant 10-fold increase in their inhibitory effect on the proliferation and colony forming capacity of Panc-1 cells, with the added benefit of inducing apoptosis. In our study, both naive and proinflammatory ADMSCs were found to regulate the expression of genes associated with metastasis (MMP2, KDR, MMP9, TIMP1, IGF2R, and COL1A1) and EMT (CDH1, VIM, ZEB1, and CLDN1) in Panc-1 cells. Remarkably, both naive and proinflammatory ADMSCs demonstrated antitumor effects on Panc-1 cells. However, it was observed that anti-inflammatory ADMSCs showed tumor-promoting effects instead. Furthermore, we observed a reciprocal influence between ADMSCs and Panc-1 cells on each other's proinflammatory cytokine expressions, suggesting a dynamic interplay within the tumor microenvironment. These findings underscore the significance of both the naive state and different inflammatory phenotypes of MSCs in the microenvironment and represent a pivotal step toward the development of novel therapeutic approaches for pancreatic cancer. Understanding the intricate interactions between MSCs and cancer cells may open new avenues for targeted interventions in cancer therapy. In our study, we showed that the tumorigenic effects of ADMSCs on Panc‐1 cells were altered when stimulated via TLR4 signaling, but this effect was altered when naive ADMSCs and ADMSCs with pro‐inflammatory character stimulated by TLR4 agonist exerted anticarcinogenic effects on Panc‐1 cells. Anti‐inflammatory ADMSCs, on the other hand, showed tumor‐promoting effects. Understanding the role of MSCs in the tumor microenvironment will be a guiding factor for the development of microenvironment‐targeted therapeutic approaches in the future. |
Author | Kaçaroğlu, Demet Yaylacı, Seher Gurbuz, Nilgun |
AuthorAffiliation | 1 Department of Medical Biology, Faculty of Medicine Suleyman Demirel University Isparta Turkey 2 Department of Medical Biology, Faculty of Medicine Lokman Hekim University Ankara Turkey |
AuthorAffiliation_xml | – name: 2 Department of Medical Biology, Faculty of Medicine Lokman Hekim University Ankara Turkey – name: 1 Department of Medical Biology, Faculty of Medicine Suleyman Demirel University Isparta Turkey |
Author_xml | – sequence: 1 givenname: Demet orcidid: 0000-0003-4920-0516 surname: Kaçaroğlu fullname: Kaçaroğlu, Demet email: demetkacaroglu@gmail.com organization: Lokman Hekim University – sequence: 2 givenname: Seher orcidid: 0000-0003-3309-2303 surname: Yaylacı fullname: Yaylacı, Seher email: seher.yaylaci@lokmanhekim.edu.tr organization: Lokman Hekim University – sequence: 3 givenname: Nilgun orcidid: 0000-0003-4476-5593 surname: Gurbuz fullname: Gurbuz, Nilgun email: nilgungurbuz@sdu.edu.tr organization: Suleyman Demirel University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38379331$$D View this record in MEDLINE/PubMed |
BookMark | eNp1ks1u1DAUhS1UREvpghdAltjAYlonju14hUYj_qRBSKisLde-aV0l9mAnRbNjyZJn5Em4YaaoVOCNLd_vHp1j38fkIKYIhDyt2GnFWH3m7NCcSi2bB-SoZo1YKMmbgzvnQ3JSyjXDpVgtVfWIHPKWK815dUS-L-MYfn77MU5DyuESYnAUug7cWGjqaLThBqiNnp6vPzXIbXIYwFPrwyYVwAsPGRFPBygQ3dV2sD0tIwzUQd-jRqQbG10GO6Kyn9yIdeshJmezCzENdkc-IQ872xc42e_H5POb1-erd4v1x7fvV8v1wjW4FrzTredMaJDAQHvR1M4pD1azynZCacmZVCBar2rJuwshuGwc5rXCMvAtPyavdrqb6QKTOIhjtr2Zc9m8NckG83clhitzmW5MxVpe6Yqjwou9Qk5fJiijGUKZM9gIaSqm1rUWHI1IRJ_fQ6_TlCPmm6lWcSlYjdSzu5b-eLn9JQTOdoDLqZQMnXFhxAdNs8PQozUzj4KZR8HMo4AdL-913Ir-i92rfw09bP8PmtXyQ_O74xe92cdG |
CitedBy_id | crossref_primary_10_3390_ijms25158352 crossref_primary_10_1016_j_heliyon_2024_e29858 crossref_primary_10_1016_j_biopha_2024_117745 |
Cites_doi | 10.3748/wjg.v17.i24.2897 10.1002/IJC.31775 10.1158/0008-5472.CAN-14-0155 10.3389/FCELL.2020.00447 10.1002/JCB.25284 10.1016/j.ymeth.2008.03.006 10.3390/ijms20153827 10.1038/s41419-019-1959-5 10.1371/JOURNAL.PONE.0010088 10.1016/S0140-6736(20)30974-0 10.1016/j.tice.2020.101479 10.1371/journal.pone.0045590 10.1186/s12943-018-0858-1 10.1038/s41598-023-34915-0 10.18295/squmj.2018.18.03.002 10.15171/apb.2019.024 10.1186/S13287-022-02910-3/FIGURES/7 10.3389/fonc.2022.1047907 10.1038/nrdp.2016.22 10.1016/J.JSS.2007.12.757 10.1016/J.CIS.2019.03.002 10.1186/1756-8722-7-14 10.1155/2015/361326 10.1186/s40364-020-00228-x 10.1371/journal.pone.0006278 10.1016/j.bbcan.2013.10.004 10.1016/J.SEMCANCER.2015.02.006 10.1155/2017/4015039 10.1016/J.NEO.2016.01.005 10.2174/138920371604150429152720 10.1016/j.semcancer.2017.03.008 10.1371/journal.pone.0149876 10.5772/31933 |
ContentType | Journal Article |
Copyright | 2024 The Authors. published by John Wiley & Sons Ltd. 2024 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2024 The Authors. published by John Wiley & Sons Ltd. – notice: 2024 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. – notice: 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M7P PHGZM PHGZT PIMPY PKEHL PQEST PQGLB PQQKQ PQUKI 7X8 5PM |
DOI | 10.1002/cam4.6964 |
DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central ProQuest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni) Biological Science Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central ProQuest One Applied & Life Sciences Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Central (New) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database MEDLINE |
Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Kaçaroğlu et al |
EISSN | 2045-7634 |
EndPage | n/a |
ExternalDocumentID | PMC10831913 38379331 10_1002_cam4_6964 CAM46964 |
Genre | researchArticle Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | United States--US Germany California |
GeographicLocations_xml | – name: United States--US – name: Germany – name: California |
GrantInformation_xml | – fundername: Suleyman Demirel University Scientific Research Projects Coordination Unit funderid: TDK‐2022‐8583 – fundername: Suleyman Demirel University Scientific Research Projects Coordination Unit grantid: TDK-2022-8583 – fundername: Suleyman Demirel University Scientific Research Projects Coordination Unit grantid: TDK‐2022‐8583 |
GroupedDBID | 0R~ 1OC 24P 31~ 53G 5VS 7X7 8-0 8-1 8FE 8FH 8FI 8FJ AAHHS AAZKR ABDBF ABUWG ACCFJ ACCMX ACUHS ACXQS ADBBV ADKYN ADPDF ADRAZ ADZMN ADZOD AEEZP AENEX AEQDE AFKRA AIWBW AJBDE ALAGY ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQN AOIJS AVUZU BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI CCPQU D-8 D-9 DIK EBS EJD FYUFA GODZA GROUPED_DOAJ GX1 HCIFZ HMCUK HYE HZ~ IAO IHR ITC KQ8 LK8 M48 M7P M~E O9- OK1 OVD PIMPY PQQKQ PROAC RPM TEORI TUS UKHRP WIN AAYXX CITATION PHGZM PHGZT AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM PQGLB 3V. 7XB 8FK AZQEC DWQXO GNUQQ K9. PKEHL PQEST PQUKI 7X8 5PM |
ID | FETCH-LOGICAL-c4444-3f98d3059e6e0e9d542cc7dea901af57963067e58d7263fb55364c383a5a0ed83 |
IEDL.DBID | M48 |
ISSN | 2045-7634 |
IngestDate | Thu Aug 21 18:35:33 EDT 2025 Fri Jul 11 12:13:43 EDT 2025 Wed Aug 13 06:17:05 EDT 2025 Mon Jul 21 06:03:21 EDT 2025 Thu Apr 24 22:51:43 EDT 2025 Tue Jul 01 02:16:34 EDT 2025 Wed Jan 22 16:15:26 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | MSC1 pancreatic cancer tumor microenvironment TLR4 mesenchymal stem cells |
Language | English |
License | Attribution 2024 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4444-3f98d3059e6e0e9d542cc7dea901af57963067e58d7263fb55364c383a5a0ed83 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0003-4920-0516 0000-0003-4476-5593 0000-0003-3309-2303 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1002/cam4.6964 |
PMID | 38379331 |
PQID | 2928736502 |
PQPubID | 2032540 |
PageCount | 17 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_10831913 proquest_miscellaneous_2929539636 proquest_journals_2928736502 pubmed_primary_38379331 crossref_citationtrail_10_1002_cam4_6964 crossref_primary_10_1002_cam4_6964 wiley_primary_10_1002_cam4_6964_CAM46964 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | January 2024 |
PublicationDateYYYYMMDD | 2024-01-01 |
PublicationDate_xml | – month: 01 year: 2024 text: January 2024 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Bognor Regis – name: Hoboken |
PublicationTitle | Cancer medicine (Malden, MA) |
PublicationTitleAlternate | Cancer Med |
PublicationYear | 2024 |
Publisher | John Wiley & Sons, Inc John Wiley and Sons Inc |
Publisher_xml | – name: John Wiley & Sons, Inc – name: John Wiley and Sons Inc |
References | 2015; 35 2021; 68 2019; 9 2013; 1836 2023; 13 2015; 16 2017; 2017 2012 2019; 10 2017; 44 2019; 267 2008; 149 2011; 17 2016; 18 2019; 144 2016; 11 2020; 8 2018; 18 2018; 17 2016; 2 2019; 20 2020; 395 2015; 2015 2022; 12 2022; 13 2008; 45 2016; 117 2009; 4 2014; 74 2020; 0 2012; 7 2014; 7 2010; 5 e_1_2_11_10_1 e_1_2_11_32_1 e_1_2_11_31_1 e_1_2_11_30_1 e_1_2_11_14_1 e_1_2_11_13_1 e_1_2_11_12_1 e_1_2_11_34_1 e_1_2_11_11_1 e_1_2_11_33_1 e_1_2_11_7_1 e_1_2_11_29_1 e_1_2_11_6_1 e_1_2_11_28_1 e_1_2_11_5_1 e_1_2_11_27_1 e_1_2_11_4_1 e_1_2_11_26_1 e_1_2_11_3_1 e_1_2_11_2_1 e_1_2_11_21_1 e_1_2_11_20_1 e_1_2_11_25_1 e_1_2_11_24_1 e_1_2_11_9_1 e_1_2_11_23_1 e_1_2_11_8_1 e_1_2_11_22_1 e_1_2_11_18_1 e_1_2_11_17_1 e_1_2_11_16_1 e_1_2_11_15_1 e_1_2_11_19_1 |
References_xml | – volume: 149 start-page: 319 issue: 2 year: 2008 end-page: 328 article-title: The role of the tumor microenvironment in the progression of pancreatic cancer publication-title: J Surg Res – volume: 0 start-page: 447 year: 2020 article-title: The multifaceted roles of MSCs in the tumor microenvironment: interactions with immune cells and exploitation for therapy publication-title: Front Cell Dev Biol – volume: 13 start-page: 1 issue: 1 year: 2022 end-page: 17 article-title: Human amniotic fluid mesenchymal stem cells attenuate pancreatic cancer cell proliferation and tumor growth in an orthotopic xenograft mouse model publication-title: Stem Cell Research and Therapy – volume: 7 start-page: e45590 issue: 9 year: 2012 article-title: Mesenchymal stem cell 1 (MSC1)‐based therapy attenuates tumor growth whereas MSC2‐treatment promotes tumor growth and metastasis publication-title: PLoS One – volume: 8 start-page: 49 year: 2020 article-title: Roles of IFN‐γ in tumor progression and regression: a review publication-title: Biomark Res – volume: 1836 start-page: 321 issue: 2 year: 2013 end-page: 335 article-title: Tumor microenvironment: bone marrow‐mesenchymal stem cells as key players publication-title: Biochim Biophys Acta Rev Cancer – volume: 10 issue: 10 year: 2019 article-title: TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma publication-title: Cell Death Dis – volume: 16 start-page: 295 issue: 4 year: 2015 end-page: 300 article-title: The LPS‐pretreated MSCs supply a positive microenvironment for tumor cell proliferation and clone formation publication-title: Curr Protein Pept Sci – volume: 267 start-page: 47 year: 2019 end-page: 61 article-title: Engineering nanocellulose hydrogels for biomedical applications publication-title: Adv Colloid Interf Sci – volume: 2015 year: 2015 article-title: Lipopolysaccharide from attenuates microglia‐mediated inflammation and phagocytosis and directs regulatory T cell response publication-title: Int J Inflamm – volume: 11 issue: 3 year: 2016 article-title: TLR4 activation promotes bone marrow MSC proliferation and osteogenic differentiation via wnt3a and wnt5a signaling publication-title: PLoS One – volume: 74 start-page: 2913 issue: 11 year: 2014 end-page: 2921 article-title: Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States publication-title: Cancer Res – volume: 17 start-page: 2897 issue: 24 year: 2011 end-page: 2908 article-title: Molecular biology of pancreatic cancer publication-title: World J Gastroenterol – volume: 12 year: 2022 article-title: MSCs can be a double‐edged sword in tumorigenesis publication-title: Front Oncol – volume: 7 start-page: 1 issue: 1 year: 2014 end-page: 10 article-title: The roles of mesenchymal stem cells in tumor inflammatory microenvironment publication-title: J Hematol Oncol – volume: 2017 start-page: 1 year: 2017 end-page: 17 article-title: The immunomodulatory effects of mesenchymal stem cell polarization within the tumor microenvironment niche publication-title: Stem Cells Int – volume: 395 start-page: 2008 issue: 10242 year: 2020 end-page: 2020 article-title: Pancreatic cancer publication-title: Lancet – volume: 35 start-page: S25 issue: Suppl year: 2015 end-page: S54 article-title: Sustained proliferation in cancer: mechanisms and novel therapeutic targets publication-title: Semin Cancer Biol – volume: 20 start-page: 1 issue: 15 year: 2019 end-page: 32 article-title: Current strategies to enhance adipose stem cell function: an update publication-title: Int J Mol Sci – volume: 5 issue: 4 year: 2010 article-title: A new mesenchymal stem cell (MSC) paradigm: polarization into a pro‐inflammatory MSC1 or an immunosuppressive MSC2 phenotype publication-title: PLoS One – volume: 17 start-page: 4 issue: 108 year: 2018 end-page: 15 article-title: Tumor microenvironment participates in metastasis of pancreatic cancer publication-title: Mol Cancer – volume: 44 start-page: 153 year: 2017 end-page: 169 – volume: 18 start-page: e264 issue: 3 year: 2018 end-page: e277 article-title: Sources and clinical applications of mesenchymal stem cells state publication-title: Sultan Qaboos Univ Med J – volume: 9 start-page: 205 issue: 2 year: 2019 end-page: 218 article-title: Understanding apoptosis and apoptotic pathways targeted cancer therapeutics publication-title: Adv Pharm Bull – volume: 2 start-page: 16022 year: 2016 article-title: Pancreatic cancer publication-title: Nat Rev Dis Primers – volume: 45 start-page: 115 issue: 2 year: 2008 end-page: 120 article-title: Adipose‐derived stem cells: isolation, expansion and differentiation publication-title: Methods – volume: 144 start-page: 1401 issue: 6 year: 2019 end-page: 1413 article-title: Adipose tissue‐derived stromal cells are sources of cancer‐associated fibroblasts and enhance tumor progression by dense collagen matrix publication-title: Int J Cancer – volume: 4 start-page: e6278 issue: 7 year: 2009 article-title: Adult stromal cells derived from human adipose tissue provoke pancreatic cancer cell death both in vitro and in vivo publication-title: PLoS One – start-page: 255 year: 2012 end-page: 286 – volume: 13 start-page: 1 issue: 1 year: 2023 end-page: 14 article-title: An enzyme‐free technique enables the isolation of a large number of adipose‐derived stem cells at the bedside publication-title: Sci Rep – volume: 68 issue: August 2020 year: 2021 article-title: Evaluating the in vitro therapeutic effects of human amniotic mesenchymal stromal cells on MiaPaca2 pancreatic cancer cells using 2D and 3D cell culture model publication-title: Tissue Cell – volume: 18 start-page: 142 issue: 3 year: 2016 end-page: 151 article-title: Mesenchymal stem cells promote pancreatic tumor growth by inducing alternative polarization of macrophages publication-title: Neoplasia – volume: 117 start-page: 279 issue: 2 year: 2016 end-page: 288 article-title: Control of apoptosis in treatment and biology of pancreatic cancer publication-title: J Cell Biochem – ident: e_1_2_11_5_1 doi: 10.3748/wjg.v17.i24.2897 – ident: e_1_2_11_30_1 doi: 10.1002/IJC.31775 – ident: e_1_2_11_2_1 doi: 10.1158/0008-5472.CAN-14-0155 – ident: e_1_2_11_10_1 doi: 10.3389/FCELL.2020.00447 – ident: e_1_2_11_23_1 doi: 10.1002/JCB.25284 – ident: e_1_2_11_16_1 doi: 10.1016/j.ymeth.2008.03.006 – ident: e_1_2_11_13_1 doi: 10.3390/ijms20153827 – ident: e_1_2_11_32_1 doi: 10.1038/s41419-019-1959-5 – ident: e_1_2_11_19_1 doi: 10.1371/JOURNAL.PONE.0010088 – ident: e_1_2_11_4_1 doi: 10.1016/S0140-6736(20)30974-0 – ident: e_1_2_11_21_1 doi: 10.1016/j.tice.2020.101479 – ident: e_1_2_11_14_1 doi: 10.1371/journal.pone.0045590 – ident: e_1_2_11_7_1 doi: 10.1186/s12943-018-0858-1 – ident: e_1_2_11_17_1 doi: 10.1038/s41598-023-34915-0 – ident: e_1_2_11_18_1 doi: 10.18295/squmj.2018.18.03.002 – ident: e_1_2_11_24_1 doi: 10.15171/apb.2019.024 – ident: e_1_2_11_31_1 doi: 10.1186/S13287-022-02910-3/FIGURES/7 – ident: e_1_2_11_34_1 doi: 10.3389/fonc.2022.1047907 – ident: e_1_2_11_3_1 doi: 10.1038/nrdp.2016.22 – ident: e_1_2_11_9_1 doi: 10.1016/J.JSS.2007.12.757 – ident: e_1_2_11_20_1 doi: 10.1016/J.CIS.2019.03.002 – ident: e_1_2_11_8_1 doi: 10.1186/1756-8722-7-14 – ident: e_1_2_11_28_1 doi: 10.1155/2015/361326 – ident: e_1_2_11_25_1 doi: 10.1186/s40364-020-00228-x – ident: e_1_2_11_29_1 doi: 10.1371/journal.pone.0006278 – ident: e_1_2_11_26_1 doi: 10.1016/j.bbcan.2013.10.004 – ident: e_1_2_11_22_1 doi: 10.1016/J.SEMCANCER.2015.02.006 – ident: e_1_2_11_11_1 doi: 10.1155/2017/4015039 – ident: e_1_2_11_33_1 doi: 10.1016/J.NEO.2016.01.005 – ident: e_1_2_11_15_1 doi: 10.2174/138920371604150429152720 – ident: e_1_2_11_6_1 doi: 10.1016/j.semcancer.2017.03.008 – ident: e_1_2_11_27_1 doi: 10.1371/journal.pone.0149876 – ident: e_1_2_11_12_1 doi: 10.5772/31933 |
SSID | ssj0000702671 |
Score | 2.300397 |
Snippet | Background
One of the main reasons for the unsuccessful treatment of pancreatic cancer is the intense desmoplastic pancreatic microenvironment. In the... One of the main reasons for the unsuccessful treatment of pancreatic cancer is the intense desmoplastic pancreatic microenvironment. In the literature, the... BackgroundOne of the main reasons for the unsuccessful treatment of pancreatic cancer is the intense desmoplastic pancreatic microenvironment. In the... In our study, we showed that the tumorigenic effects of ADMSCs on Panc‐1 cells were altered when stimulated via TLR4 signaling, but this effect was altered... |
SourceID | pubmedcentral proquest pubmed crossref wiley |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | e6964 |
SubjectTerms | Adenocarcinoma Adipose Tissue Angiogenesis Anti-Inflammatory Agents Antitumor activity Apoptosis Body fat Cancer therapies Carcinoma, Pancreatic Ductal - genetics Carcinoma, Pancreatic Ductal - metabolism Carcinoma, Pancreatic Ductal - therapy Cell cycle Cell growth Cell proliferation Collagen (type I) Cytokines E-cadherin Experiments Gelatinase A Gelatinase B Genotype & phenotype Humans Inflammation Insulin-like growth factor II receptors Liposuction Mesenchymal stem cells Mesenchymal Stem Cells - metabolism Metastases Metastasis MSC1 Mutation Pancreatic cancer Pancreatic Neoplasms - genetics Pancreatic Neoplasms - metabolism Pancreatic Neoplasms - therapy Penicillin Phenotypes Stem cells Tissue inhibitor of metalloproteinase 1 TLR4 TLR4 protein Toll-Like Receptor 4 - genetics Toll-Like Receptor 4 - metabolism Toll-like receptors Tumor Microenvironment Tumors |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9QwELWgSIgL4ptAQQZx4GKaxHYSn9CqoqoQywG10t4ix56oKxFn6e5W6pVfzkziDawK7CkrT-Q4Mx6_mdhvGHvXOAOI6p1QvlJCgQZRqQZjHq0ghVQql9Lh5PnX4vRcfV7oRUy4reO2yp1PHBy17x3lyI9yg9heIp7IP65-CKoaRV9XYwmN2-wOUZdR8FUuyinHguacF2W2IxRK8yNnO_WhMIXaX4ZuYMubWyT_hK7D2nPygN2PoJHPRi0_ZLcgPGJ35_Gz-GP2cxY2S7HZdvTAEJaOx20avG95sOjQuA2en335psSK-Pw9t3656tcgPFrgFf7v6BSSu7jusB_iduaU0cf7A0d3MSJLx4kbFtst-ipcAi-x876zo-QTdn7y6ez4VMTiCsIp_AnZmsrjZDdQoFKM1yp3rvRgESDYlk6oUjABuvJlXsi20VoWymE8a7VNwVfyKTsIfYDnjGe2kVTlqiwdHevVRmqrHShoLWQgTcLe79517SLzOBXA-F6PnMl5TWqpSS0JezuJrka6jb8JHe4UVscZt65_20fC3kzNOFfoJdgA_XaQMVriyIqEPRv1O_VCkbqRMktYtaf5SYB4uPdbwvJi4OPOqFqbySSOczCSfz95fTybK7p48f8hvGT3cgRPY6rnkB1sLrfwCsHPpnk9WPgvBYAGHQ priority: 102 providerName: ProQuest – databaseName: Wiley Online Library Open Access dbid: 24P link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fa9RAEB5qBfGl-NtolVV88CU2ye7msvh0FEsRT0Ra6FvY7E7ogdkcvbuCb33so3-jf4kzSS56VME8hewkm2Rmdr_ZZL4BeFM5g4TqXax8oWKFGuNCVRTzaIUJJlK5hJOTZ5_z41P18Uyf7cD7TS5Mzw8xLrixZ3TjNTu4rZYHv0lDnW3Uu9zk6hbc5tRaNvJMfRkXWMiWs7wLuJhxPSY_UhtmoSQ7GM_eno9ugMyb_0r-iWG7SejoHuwN6FFMe3Xfhx0MD-DObPg-_hCup2E1_3n1Y7VuuOIVhrkTwx8boq1FsDS2CRu8OPn0VZHcgsn9vbB-vmiXSAc8GeQlHWk4Kcmdf2-oN6Z6FrzAT9cIgkaPHmg6wVSx1G5p6KIZ8YJuoW1sL_kITo8-nBwex0Othdgp2mJZm8KT7xvMSUfGa5U5N_FoCS_YmhNWObZAXfhJlsu60lrmylF4a7VN0BfyMeyGNuBTEKmtJBe9mkwcZ_lqI7XVDhXWFlOUJoK3mzdeuoGInOthfCt7CuWsZOWUrJwIXo-ii559429C-xu1lYMDLsvMUCgoCX5mEbwam8l1-CXYgO26kzFa0pPlETzptTz2woG7kTKNoNjS_yjAtNzbLWF-3tFzp1y8zaSSnrMzlX_feXk4nSneefb_os_hbka4ql8F2ofd1cUaXxAuWlUvO_v_BW_NDUc priority: 102 providerName: Wiley-Blackwell |
Title | Anti‐tumorigenic effects of naive and TLR4‐primed adipose‐derived mesenchymal stem cells on pancreatic ductal adenocarcinoma cells |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcam4.6964 https://www.ncbi.nlm.nih.gov/pubmed/38379331 https://www.proquest.com/docview/2928736502 https://www.proquest.com/docview/2929539636 https://pubmed.ncbi.nlm.nih.gov/PMC10831913 |
Volume | 13 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1ba9swFD70AmMvY_d564I29rAXd7El2dbDGFlpV8ZSSmkgb0aWZBqo5SxNSvu6X75zfAkN7WB-MA46RraOjvQdxfo-gE-FUQ5RvQmFzUQonHRhJgrMeaRwQzfkwgxpc_L4JDmeiJ9TOd2CXmOza8CrB1M70pOaLC73b37ffsOA_9oRiH4xuhL7iUrENuzihJSSgsO4Q_nNgJySzBKlXsS9HmJEiZ5j6O7dmzPTPbh5_6vJu2i2mY6OnsKTDkeyUev4Z7Dl_HN4NO7-KX8Bf0Z-OQuXq4qUr5yfGdZ9ucHqknmNYxzT3rLzX2cinBPFv2Xazub1lQstdspr_F3RxiRzcVthPUT3zGiRH-_3DEeQFmwaRnSxWK5x-MJZcYGV15VuLV_C5Ojw_OA47PQWQiPwCHmpMovxr1yCflJWitiY1DqNmEGXtGmV8gsnM5vGCS8LKXkiDKa4Wuqhsxl_BTu-9u4NsEgXnISv0tTQTl-puNTSOOFK7SLHVQCf-7bOTUdGTpoYl3lLoxzn5Jac3BLAx7XpvGXgeMhor3dY3vehPFaYDnKEoHEAH9bFGD7UCNq7etXYKMnxzZIAXrf-XddCybviPAog2_D82oCouTdL_OyioeiOSMBNRRzfs-kk_37y_GA0FnTx9j-e8R08jhFUtUtAe7CzXKzcewRFy2IA27E4xXM6TQew-_3w5PRs0Cww4PnHNBo0IfEXwnwQ_w |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTgJeEN8UBhgEEi9hSWyn8QNCZWzqWFuhqZP2ljm2o1Vakm5tQXvlD-Jv5K75gGrA2_KUyJc49p3vfv64O4A3qVEOUb3xhI2FJ5x0XixSnPNI4Xznc2F8ck4ejaPBkfhyLI834GfjC0PHKhuduFLUtjS0Rr4dKsT2HPFE-HF27lHWKNpdbVJoVGJx4C6_45Rt_mH_M_L3bRju7U52Bl6dVcAzAi-PZyq2KOXKRfg3ykoRGtOzTqNl1Bm5ZhKKdjK2vTDiWSolj4TBiZyW2nc25vjdG7ApOEKFDmx-2h1_PWxXdXAAhVEvaEIY-eG20bl4H6lIrBu-K2j26qHMP8Hyytrt3YU7NUxl_Uqu7sGGK-7DzVG9Ef8AfvSLxdRbLHPqIldMDasPhrAyY4VGFcp0YdlkeCi8GWUQsEzb6aycO8-izH_D55z8nszpZY71UDRpRnsI-H7BUEFVWNYwikaL5Rq1IxrdC6y8zHVF-RCOrqXjH0GnKAv3BFigU055tXo9Q47EUnGppXHCZdoFjqsuvGv6OjF1rHNKuXGWVFGaw4TYkhBbuvC6JZ1VAT7-RrTVMCypx_g8-S2RXXjVFuPopE7QhSuXKxolObYs6sLjir9tLbQ2oDgPuhCvcb4loMjf6yXF9HQVATyg_HAq4NjOlZD8-8-Tnf5I0M3T_zfhJdwaTEbDZLg_PngGt0OEbtVC0xZ0FhdL9xyh1yJ9Ucs7g5PrHmK_ANIDQxY |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VIlVcEG8MBRYEEhfT2Ltrew8IRS1RS5sKoVbKzax3x2okvA5NAuqVn8WvY8aPQFTg1pwc7dj7mNe3rxnGXhZWA6J6G0qXyVCCgjCTBc55lIQBDIS0A7qcPD5O9k_lh4mabLCf_V0YOlbZ28TGULva0hr5TqwR2wvEE_FO2R2L-Lg3ejf7GlIGKdpp7dNptCJyCBffcfo2f3uwh7x-Fcej9ye7-2GXYSC0En-hKHXmUOI1JNgy7ZSMrU0dGPSSpqRrmoSoQWUujRNRFkqJRFqc1BllBuAygd-9xq6nAt0m6lI6SVfrO6hKcZJGfTAjbLY1lXyT6ESuu8BLuPby8cw_YXPj90a32M0OsPJhK2G32Qb4O2xr3G3J32U_hn4xDRfLigYI_NTy7ogIr0vuDRpTbrzjJ0efZDijXAKOGzed1XMIHUr_N_xf0Q0oe3ZRYT0UV5rTbgK-7zmaqhbVWk5xabHcoJ1E93uOldeVaSnvsdMrGfb7bNPXHh4yHplCUIatNLV0pVhpoYyyIKE0EIHQAXvdj3Vuu6jnlHzjS97Ga45zYktObAnYixXprA318Tei7Z5heaft8_y3bAbs-aoY9ZQGwXiolw2NVgJ7lgTsQcvfVS20SqCFiAKWrXF-RUAxwNdL_PSsiQUeUaY4HQnsZyMk_255vjscS3p49P8uPGNbqFj50cHx4WN2I0YM1644bbPNxfkSniAGWxRPG2Hn7PNVa9cvM2RF5g |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Anti-tumorigenic+effects+of+naive+and+TLR4-primed+adipose-derived+mesenchymal+stem+cells+on+pancreatic+ductal+adenocarcinoma+cells&rft.jtitle=Cancer+medicine+%28Malden%2C+MA%29&rft.au=Ka%C3%A7aro%C4%9Flu%2C+Demet&rft.au=Yaylac%C4%B1%2C+Seher&rft.au=Gurbuz%2C+Nilgun&rft.date=2024-01-01&rft.issn=2045-7634&rft.eissn=2045-7634&rft.volume=13&rft.issue=2&rft.spage=e6964&rft_id=info:doi/10.1002%2Fcam4.6964&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-7634&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-7634&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-7634&client=summon |